Management of Patients with Coronary Stents and GI Bleeding History

Medication Management

The American College of Gastroenterology recommends that patients with a history of GI bleeding should discontinue all NSAIDs and aspirin-containing products to minimize the risk of further bleeding 1
The European Society of Cardiology suggests switching from prasugrel to clopidogrel 75 mg daily in patients with stable coronary artery disease and a history of GI bleeding, as prasugrel increases the risk of bleeding in these patients 2, 3
The American Heart Association recommends continuing proton pump inhibitors (PPIs) such as pantoprazole 40 mg twice daily indefinitely in patients on dual antiplatelet therapy with a history of GI bleeding 1, 5

The European Society of Cardiology recommends urgent neurological evaluation for severe headaches with red flag features, including intensity, radiation, and associated symptoms such as blurry vision and nausea 3, 5
The American College of Radiology suggests urgent brain MRI with and without contrast to exclude mass lesions, hemorrhage, or vascular abnormalities in patients with severe headaches and red flag features 5

The American Society of Hematology recommends checking complete blood count, iron studies, and stool occult blood test to assess current anemia status and ensure no ongoing GI bleeding in patients with a history of melena requiring transfusion [4, @8@]
The European Society of Cardiology suggests that hemoglobin should be >12 g/dL before considering any elective procedures in patients with a history of GI bleeding 4, 7

The American College of Cardiology recommends establishing care with a new cardiologist immediately in patients with recent stent placement requiring DAPT monitoring, medication optimization, and evaluation of chest pain symptoms 2, 4, 5
The European Society of Cardiology suggests assessing DAPT duration, typically 6 months for stable CAD, but potentially shortened to 3 months given high bleeding risk 5, 7, 4